Global Atelocollagen Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Atelocollagen Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Atelocollagen is a low-immunogenic derivative of collagen obtained by removal of N- and C-terminal telopeptide components, which are known to induce antigenicity in humans. Telopeptides are removed by treatment of collagen with type I pepsin. The resulting atelocollagen (300 kDa) has a stick-like structure, 300 nm in length and 1.5 nm in diameter. One advantage of atelocollagen compared to other experimental carriers is that it is already used clinically in a variety of applications, including wound healing, and as a bone cartilage substitute and haemostatic agent.

Atelocollagen is a water-soluble form of collagen, which is widely used in Beauty and Pharmaceuticals.

Market Overview:

The latest research study on the global Atelocollagen market finds that the global Atelocollagen market reached a value of USD 990.84 million in 2022. It’s expected that the market will achieve USD 1575.37 million by 2028, exhibiting a CAGR of 8.03% during the forecast period.

Influence of COVID-19 Outbreak on Atelocollagen Industry Development

The raging COVID-19 plunged the global economic environment into depression. The impact of COVID-19 on the collagen industry will involve all major links and all entities in the industry chain. The company's management efficiency has declined, commuting has been severely hindered, production plans have been severely hindered, network expansion has been delayed, marketing has been delayed, brand adjustments have been forced, market sales have declined, and company and employee revenue have declined. The government has also put forward higher requirements for the production and operation of enterprises.

The COVID-19 outbreak has been posing staggering health and humanitarian challenges. As with many industries, retail and consumer products industry has been particularly affected, with companies struggling with demand that is either evaporating or increasing over the available supply. Additionally, factory closures, movement restrictions, and supply chain disruptions induced by the current crisis are resulting in product shortages in the Atelocollagen Market in 2020.

In the short term, from the supply side, the company's operating pressure will increase due to postponement of workers' arrival and logistics and transportation issues. In the long run, as the epidemic gradually improves or ends, the impact on the atelocollagen industry will gradually weaken. Production and sales will return to the original level and gradually increase.

Atelocollagen Market Challenges

In order to curb the COVID-19 epidemic, most countries have introduced many policies, including border blockade and social distancing. The epidemic prevention and control measures will affect the flow of people and activities, and in turn affect logistics, making the production of manufacturing, especially labor-intensive industries, affected by the supply of raw materials and labor shortages.

For the Atelocollagen Raw Material industry, the blockade policy will affect the supply of raw materials and export trade of products. The social distancing policy may have a great impact on the production of products, especially for some small factories, they will spend more money to maintain production during the epidemic, and factories may face the risk of closure in some areas. With the gradual control of the epidemic, some factories began to resume operation. However, while operating production, enterprises need to protect the life and health of employees, such as purchasing masks, disinfectants and other epidemic prevention materials, disinfecting the working environment before and after the production, and testing the body temperature of employees every day to ensure the health of employees. These measures will increase the production cost of enterprises and affect the development of enterprises.

But in the long term, the COVID-19 outbreak may cause more factories to start using more automated production lines to avoid the pandemic's impact on the industry. In addition, the application of IoT technology may also bring more opportunities for industry participants.

Region Overview:

From 2023-2028, North America is estimated to witness robust growth prospects.

Company Overview:

Integra LifeSciences is one of the major players operating in the Atelocollagen market, holding a share of 31.62% in 2021.

Integra LifeSciences, a world leader in medical technology with headquarters in Princeton, New Jersey, was founded in 1989 with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has expanded its base regenerative technology product portfolio to include surgical instruments, neurosurgical products and advanced wound care products, through global acquisitions and development of new and innovative products and technologies to address unmet patient needs and improve outcomes.

Integra is a global leader in neurosurgery and offers a broad portfolio of products and solutions for dural access and repair, cerebral spinal fluid management and neuro-critical care. Integra regenerative tissue technologies include products that address soft tissue, nerve and tendon repairs and for the treatment of acute and chronic wounds, burns, as well as for plastic and reconstructive surgery. The company has offices, manufacturing and research facilities in Asia, Australia, Europe, Middle East, and the Americas.

Royal DSM is a purpose-led global science-based company in Nutrition, Health and Sustainable Living. DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative business solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM has about 23,000 employees.

Segmentation Overview:

Among different product types, Bovine Collagen segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Medical segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Atelocollagen market covered in Chapter 3:

Rousselot
DSM Biomedical
Sewon Cellontech
Integra LifeSciences
KOKEN
EnColl Corporation
Getinge
Symatese
Collagen Matrix
Sunmax
Guangzhou Trauer Biotechnology
Collagen Solutions
Wuxi Biot Bio-technology
Guangdong Victory Biotech
Innocoll

In Chapter 4 and Chapter 14.2, on the basis of types, the Atelocollagen market from 2018 to 2029 is primarily split into:

Bovine Collagen
Porcine Collagen
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Atelocollagen market from 2018 to 2029 covers:

Beauty
Medical
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)